Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Latin America | 2024

The COVID-19 pandemic had a short-term impact on the Latin American GI endoscopy device market because many screening and elective interventional procedures were deferred in 2020 as per safety guidelines. Following the impact, the market saw a subsequent recovery and will expand moderately through 2032 as the market observes innovation in diagnostic and interventional applications of GI endoscopy. Healthcare policies and physician awareness continue to evolve in the region, favoring procedure volume growth for GI endoscopy.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Latin America from 2019 through 2032.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market is projected to experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Latin America
The Latin American GI endoscopy devices market is projected to grow moderately through 2034, driven by ongoing innovation in both diagnostic and interventional applications of GI endoscopy…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Gynecological Devices – Market Insights – Latin America
The Latin American gynecological device market will experience modest growth over the forecast period, driven primarily by increasing awareness of gynecological health and available treatment…
Report
Gastrointestinal Endoscopy Devices – Market Insights – United States
The US GI endoscopy device market is projected to experience modest expansion through 2034. The market growth is being driven by supportive treatment and screening guidelines, the growing use of AI…